ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.80
1.57%
다우존스 지수
38,239.66
0.40%
Bitcoin
62,669.64
-0.69%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Ligand Pharmaceuticals Incorporated (LGND)

  7. Ligand Pharmaceuticals Incorporated (LGND) 뉴스

LGND Ligand Pharmaceuticals Incorporated

70.57
0.20 (0.28%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Ligand Pharmaceuticals Incorporated LGND 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.20 0.28% 70.57 07:36:58
개장가 저가 고가 종가 전일 종가
70.59 70.21 72.085 70.57 70.37
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
08/03/202403:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/03/202407:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202408:12EDGAR2Form 144 - Report of proposed sale of securities
02/03/202406:09EDGAR2Form S-8 - Securities to be offered to employees in employee..
01/03/202408:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202408:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202408:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202408:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202406:49EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
29/02/202408:05EDGAR2Form 144 - Report of proposed sale of securities
29/02/202407:43EDGAR2Form 144 - Report of proposed sale of securities
27/02/202421:24EDGAR2Form 8-K - Current report
17/02/202410:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202410:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202410:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202410:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/02/202420:26EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/02/202405:39EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
11/01/202409:30GLOBEHenlius and Sermonix Announce Strategic Collaboration and..
06/01/202407:40DJNLigand Pharmaceuticals Gets FDA OK for Viral Skin Infection..
05/01/202406:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202305:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202305:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202322:25EDGAR2Form 8-K - Current report
01/12/202322:20GLOBEPalvella Therapeutics and Ligand Pharmaceuticals Expand..
28/11/202323:01GLOBESermonix Pharmaceuticals Announces Five Abstracts Accepted..
10/11/202311:48EDGAR2Form 8-K/A - Current report: [Amend]
10/11/202307:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202306:08EDGAR2Form 8-K - Current report
06/11/202323:00GLOBESermonix Pharmaceuticals Announces JCO Precision Oncology..
18/10/202322:03EDGAR2Form 8-K - Current report
18/10/202321:00GLOBEOvid Therapeutics and Ligand Pharmaceuticals Enter into a..
04/10/202305:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202322:00GLOBESermonix Pharmaceuticals Shares Results of EQUALS 2 Survey..
27/09/202321:38EDGAR2Form 8-K - Current report
27/09/202305:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/09/202305:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/09/202306:26EDGAR2Form 8-K - Current report
15/08/202305:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/08/202305:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/08/202305:02EDGAR2Form 8-K - Current report
17/07/202321:45GLOBENovan Enters into Agreement to Sell Substantially All of its..
11/07/202307:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/07/202307:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/06/202322:00GLOBESermonix Pharmaceuticals to Present Two Posters at The..
05/06/202322:01GLOBESermonix Pharmaceuticals Shares ASCO Poster Presentation on..
26/05/202306:00GLOBESermonix Pharmaceuticals to Share Longer Patient Follow-up..

최근 히스토리

NASDAQ
LGND
Ligand Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유